Psychiatric outcomes following medical and surgical abortion

Human Reproduction

Volumn 22, Issue 3, 2007, Pages 878-884

  Sit, Dorothy ^a   Rothschild, Anthony J ^b   Creinin, Mitchell D ^a,c,d   Hanusa, Barbara H ^a   Wisner, Katherine L ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d Medical and Laboratory Directory   (United States)

Author keywords

Biomarker; Depression; Mifepristone; Salivary cortisol

Indexed keywords

ABORTIVE AGENT; ANTIDEPRESSANT AGENT; HYDROCORTISONE; MIFEPRISTONE;

ADOLESCENT; ADULT; ARTICLE; CHEMISTRY; CURETTAGE; DEPRESSION; FEMALE; HUMAN; INDUCED ABORTION; METHODOLOGY; MOOD DISORDER; PREGNANCY; PSYCHOLOGICAL ASPECT; SALIVA;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; MIFEPRISTONE; MOOD DISORDERS; PREGNANCY; SALIVA; VACUUM CURETTAGE;

EID: 34247876131     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del450     Document Type: Article

References (34)

1. American College of Obstetrics Gynecology (ACOG) (2005) ACOG practice bulletin. Clinical management guidelines of obstetrician-gynecologists. Number 67, October 2005. Medical management of abortion. Obstet Gynecol 106(4), 871-882.
2. Anton RF (1987) Urinary free cortisol in psychotic depression. Biol Psychiatry 22,24-34.
3. Ashok PW, Hamoda H, Flett GMM, Kidd A, Fitzmaurice A and Templeton A (2005) Psychological sequelae of medical and surgical abortion at 10-13 weeks gestation. Acta Obstet Gynecol Scand 84,761-766.
4. Belanoff J, Rothschild AJ, Cassidy F, DeBattista C, Baulieu E, Schold C and Schatzberg AF (2002) An open label trial of C-1073 (Mifepristone) for psychotic major depression. Biol Psychiatry 52,386-392.
5. Blazer DG, Kessler RC, McGonagle KA and Swartz MS (1994) The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry 151,979-986.
6. Cohen J (1992) A power primer. Psychological Bulletin 112,155-159.
7. Cox JL, Holden JM and Sagovsky R (1987) Detection of Postnatal Depression-development of the 10-Item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150,782-786.
8. Cox JL, Chapman G, Murray D and Jones P (1996) Validation of the Edinburgh Postnatal Depression Scale (EPDS) in non-postnatal women. J Affect Disord 39(3),185-189.
9. DeBattista C and Belanoff J (2006) The use of mifepristone in the treatment of neuropsychitaric disorders. Trends Endocrinol Metab 17,117-121.
10. DeBattista C et al. (2003) C-1073 (mifepristone) versus placebo add on to usual treatment of psychotic major depression. [Abstract]. American College of Neuropsycholopharmacology, Annual Meeting. San Juan, Puerto Rico.
11. Eberhard-Gran M, Eskild A, Tambs K, Opjordsmoen S and Samuelsen SO (2001) Review of validation studies of the Edinburgh Postnatal Depression Scale. Acta Psychiatrica Scandinavica 104(4),243-249.
12. Edwards S, Clow A, Evans P and Hucklebridge F (2001) Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity. Life Sci 68,2093-2103.
13. Flores BH, Kenna H, Keller J, Solvason HB and Schatzberg AF (2006) Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31,628-636.
14. Garel M, Blondel B, Lelong N, Papin C, Bonenfant S and Kminski M (1992) Depressive reaction after miscarriage. Contracept Fertil Sex 20,75-81.
15. Gold PW, Loriaux DL and Roy A et al. (1986) Responses to corticotropin releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. N Eng J Med 314,1329-1335.
16. Gold PW, Drevets WC and Charney DS (2002) New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 52,381-385.
17. Heikinheimo O, Raivio T, Honkanen H, Ranta S and Janne OA (2003) Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity. J Clin Endocrinol Metabol 88(1),323-326.
18. Heim C, Newport DJ, Bonsall R, Miller AH and Nemeroff CB (2001) Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158,575-581.
19. Hemmerling A, Siedentopf F and Kentenich H (2005) Emotional impact and acceptability of medical abortion with mifepristone: a German experience. J Psychosomat Obstet Gynecol 26(1),23-31.
20. Henshaw SK, Koonin LM and Smith JC (1991) Characteristics of US women having abortions, 1987. Fam Plann Perspect 23,75-81.
21. Henshaw R, Simon N, Russell I and Templeton A (1994) Psychological responses following medical abortion and surgical vacuum extraction. Acta Obstet Gynecol, Scand 73,812-818.
22. Kumar A, Alcser K and Grunhaus L et al. (1986) Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia. Biol Psychiatry 21,436-444.
23. Major B, Cozzarelli C, Cooper ML, Zubek J, Richards C, Wilhite M and Gramzow RH (2000) Psychological responses of women after first-trimester abortion. Arch Gen Psych 57(8),777-784.
24. Murray L and Carothers AD (1990) The validation of the Edinburgh Post-natal Depression Scale on a community sample. Br J Psychiatry 157,288-290.
25. Neugebauer R, Kline J, O'Connor P, Shrout P, Johnson J and Skodol A et al. (1992) Determinants of depressive symptoms in the early weeks after miscarriage. Am J Public Health 82,1332-9.
26. O'Hara MW and Swain AM (1996) Rates and risk of postpartum depression: a meta analysis. Int Rev Psychiatry 8,37-54.
27. Peindl KS, Wisner KL and Hanusa BH (2004) Identifying depression in the first postpartum year: guidelines for office-based screening and referral. J Affective Disord 80,37-44.
28. Rothschild AJ, Schatzberg AF, Rosenbaum AH, Stahl JB and Cole JO (1982) The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Br J Psychiatry 141,471-474.
29. Simpson GM, Sheshai AE, Loza N, Kingsbury SJ, Fayek M, Rady A and Fawzy W (2005) An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. J Clin Psychiatry 66,598-602.
30. Urquhart DR and Templeton AA (1991) Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion. Br J Obstet Gynaecol 98(4),396-399.
31. Westhoff C, Picardo L and Morrow E (2003) Quality of life following early medical or surgical abortion. Contraception 67,41-47.
32. Yehuda R, Halligan SL, Golier JA, Grossman R and Biere LM (2004) Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology 29, 389-404.
33. Zigmond AS and Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67,361-370.
34. Zolese G and Blacker CV (1992) The psychological complications of therapeutic abortion. Br J Psychiatry 160,742-749.